This webinar highlighted the importance of analgesia and pain management in laboratory rodents with a focus on a novel injectable buprenorphine extended-release analgesic.
Epicur’s new Buprenorphine ER is a long-acting Buprenorphine SR analgesic, specifically developed for research rats and mice.
Developed with input from laboratory animal veterinarians, scientists, research personnel, vivarium directors and distributors across North America and Europe.
Learn more about our new, longer-lasting buprenorphine for your lab or facility—get the brochure!
This webinar highlighted the importance of analgesia and pain management in laboratory rodents with a focus on a novel injectable buprenorphine extended-release analgesic.
This webinar covered rodent pain management and a new long-acting buprenorphine that’s easier to use and improves comfort.
Buprenorphine ER is a long-acting buprenorphine analgesic designed for sustained pain relief in rats and mice with a single SC injection.
Labor-saving fewer interventions
Validated efficacy 72+ hours of action
Up to 6-month shelf life, resulting in fewer reorders and reduced waste
High protocol compliance reduced error margin & pharmaceutical waste, improved regulatory compliance
Regulatory-driven enhanced pain mitigation
Optimized viscosity compatible with small-gauge needles (27-30G)
Compatible with most research protocols involving post-op and post-procedure pain
|
FEATURE
|
Buprenorphine ER
|
Buprenorphine ER Alternatives
|
|---|---|---|
|
Duration
|
72-96 hours
|
|
|
Shelf Life
|
6 months (pending)
|
|
|
Labor Reduction
|
High
|
|
|
Indexing
|